Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
3.990
-0.150 (-3.62%)
At close: Mar 26, 2026, 4:00 PM EDT
4.000
+0.010 (0.25%)
Pre-market: Mar 27, 2026, 4:23 AM EDT

Purple Biotech Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8.727.414.4915.0310.89
Short-Term Investments
0.861.120.9216.6536.31
Cash & Short-Term Investments
9.578.5215.4131.6847.2
Cash Growth
12.32%-44.69%-51.35%-32.88%-18.35%
Accounts Receivable
---0.43-
Other Current Assets
0.290.380.381.141.27
Total Current Assets
9.878.9115.7933.2648.47
Net Property, Plant & Equipment
0.350.290.470.680.9
Other Intangible Assets
7.3627.8428.0420.6820.48
Long-Term Investments
----0.19
Other Long-Term Assets
7.7128.1328.5121.370.16
Total Assets
17.5737.0444.354.6270.2
Accounts Payable
2.071.463.532.131.47
Accrued Expenses
1.371.23.464.732.58
Current Portion of Leases
0.240.180.190.190.2
Other Current Liabilities
4.071.152.52--
Total Current Liabilities
7.753.999.77.064.25
Long-Term Leases
--0.160.320.55
Other Long-Term Liabilities
0.160.140.140.150.29
Total Long-Term Liabilities
0.160.140.30.470.84
Total Liabilities
7.914.1310.017.525.09
Common Stock
----123.95
Additional Paid-in Capital
181.65178.41172.5166.3537.64
Accumulated Other Comprehensive Income
-0.86-0.86-0.84-0.85-0.86
Retained Earnings
-171.08-144.69-137.45-117.57-95.91
Total Common Shareholders' Equity
9.7132.8634.2146.9164.83
Minority Interest
-0.060.050.090.190.28
Shareholders' Equity
9.6632.9134.347.165.11
Total Liabilities & Equity
17.5737.0444.354.6270.2
Total Debt
0.240.180.350.520.75
Net Cash (Debt)
9.338.3415.0631.1746.45
Net Cash Growth
11.86%-44.62%-51.68%-32.90%-18.38%
Net Cash Per Share
19.435.0913.6134.482.64
Book Value
9.7132.8634.2146.9164.83
Book Value Per Share
20.2420.0430.9151.893.69
Tangible Book Value
2.355.026.1626.2344.35
Tangible Book Value Per Share
4.903.065.5729.012.52
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q